Low grade includes PanIN-1 and PanIN-2
High grade includes PanIN-3 and carcinoma in situ
•
Low grade: Mild to moderate nuclear atypia
•
High grade: Marked nuclear atypia, loss of polarity, cribriforming, luminal necrosis
Top Differential Diagnoses
•
Intraductal papillary mucinous neoplasm
•
Reactive ductal epithelial changes
•
Intraductal spread of invasive carcinoma (cancerization of ducts)
Diagnostic Checklist
•
High-grade PanIN should be noted in pathology reports, especially in absence of invasive carcinoma
•
Low-grade PanIN does not need to be reported, does not affect surgical management
TERMINOLOGY
Abbreviations
•
Pancreatic intraepithelial neoplasia (PanIN)
Synonyms
•
Dysplasia, carcinoma in situ
Definitions
•
Noninvasive pancreatic intraductal epithelial proliferation, likely precursor of pancreatic ductal adenocarcinoma
ETIOLOGY/PATHOGENESIS
Molecular Progression
•
Early: Telomerase shortening,
KRAS2 activation
•
Intermediate: Inactivation of p16/
CDKN2A
•
Late: Inactivation of
TP53,
DPC4 /
SMAD4
•
p16 inactivation is seen in ∼ 30-50% low-grade, 70% high grade, 95% ductal adenocarcinomas
•
KRAS mutation is seen in ∼ 40-80% low-grade, > 80% high-grade, > 90% ductal adenocarcinomas
CLINICAL ISSUES
Natural History